453 related articles for article (PubMed ID: 22059486)
1. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
[TBL] [Abstract][Full Text] [Related]
2. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
[TBL] [Abstract][Full Text] [Related]
3. Landiolol: A Review in Tachyarrhythmias.
Syed YY
Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
[TBL] [Abstract][Full Text] [Related]
4. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
[TBL] [Abstract][Full Text] [Related]
5. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
[TBL] [Abstract][Full Text] [Related]
6. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting β1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicenter, randomized, double-blind, placebo-controlled study.
Taenaka N; Kikawa S
Am J Cardiovasc Drugs; 2013 Oct; 13(5):353-64. PubMed ID: 23818039
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of landiolol hydrochloride, an ultra short-acting beta-blocker].
Tanaka S; Kikuchi C; Saito N; Kasuya S
Kyobu Geka; 2008 Dec; 61(13):1096-101. PubMed ID: 19068694
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
[TBL] [Abstract][Full Text] [Related]
11. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
[TBL] [Abstract][Full Text] [Related]
12. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
[TBL] [Abstract][Full Text] [Related]
13. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
Tokunaga C; Hiramatsu Y; Kanemoto S; Takahashi-Igari M; Abe M; Horigome H; Sakakibara Y
Ann Thorac Surg; 2013 May; 95(5):1685-8. PubMed ID: 23506630
[TBL] [Abstract][Full Text] [Related]
14. [Effect of intra-operative low-dose infusion of landiolol hydrochloride on post-operative atrial fibrillation after off-pump coronary artery bypass grafting].
Wakamatsu H; Takase S; Sato Y; Seto Y; Kurosawa H; Yokoyama H
Kyobu Geka; 2010 Aug; 63(9):764-8. PubMed ID: 20715455
[TBL] [Abstract][Full Text] [Related]
15. Bolus administration of landiolol, a short-acting, selective beta1-blocker, to treat tachycardia during anesthesia: a dose-dependent study.
Harasawa R; Hayashi Y; Iwasaki M; Kamibayashi T; Mashimo T
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):793-5. PubMed ID: 17138082
[TBL] [Abstract][Full Text] [Related]
16. [Successful control of rapid heart rate in a patient with atrial fibrillation by continuous intravenous administration of landiolol hydrochloride].
Konishi R; Maeda R; Endo I; Inoue N; Seo N
Masui; 2003 May; 52(5):515-8. PubMed ID: 12795134
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
[TBL] [Abstract][Full Text] [Related]
18. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Nakasu Y; Mizutani H; Sumitani K
J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
[TBL] [Abstract][Full Text] [Related]
19. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
Yamashita T; Saitoh T; Matsushita M
J Cardiol; 2015 Jul; 66(1):69-72. PubMed ID: 25454208
[TBL] [Abstract][Full Text] [Related]
20. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
